USA USA: 1-631-626-9181 Europe Europe: 44-208-144-6005  


Tissue samples, tissue arrays, cells, microorganisms, probes and services for your research.

Web Search    Google
Featured Products
Ordering Information

Payment methods we support:
✭ Invoice / Purchase Order
✭ Credit card

ActoFactor™ Recombinant Human Tumor necrosis factor (151 aa variant)

  • Specification
  • Recommended Products
TNF is secreted by macrophages, monocytes, neutrophils, T-cells, NK-cells following their stimulation by bacterial LPS. The synthesis of TNF-α is induced by many different stimuli including interferons, IL2 and GM-CSF. It is a potent lymphoid factor which exerts cytotoxic effects on a wide range of tumor cells and certain other target cells. The clinical use of the potent anti-tumor activity of TNF-α has been limited by the proinflammatory side effects including fever, dose-limiting hypotension, hepatotoxicity, intravascular thrombosis and hemorrhage. Thus, designing clinically applicable TNF-α mutants with low systemic toxicity has been of great pharmacological interest. Human TNF-α, which only binds to the murine TNF-R55, exhibits retained anti-tumor activity and reduced systemic toxicity in mice compared with the murine TNF-α. Based on these results, many TNF-α mutants that selectively bind to TNF-R55 have been designed. These mutants displayed cytotoxic activities on tumor cell lines in vitro and exhibited lower systemic toxicity in vivo. Compared with the wild-type, recombinant human TNF-alpha Variant/Mutant has an amino acid sequence deletion from a.a. 1-7, and the following a.a. substitutes Arg8, Lys9, Arg10 and Phe157. It is proven to have more activity and less inflammatory side effects in vivo. Recombinant Human TNF-α Variant produced in E. coli is a single, non-glycosylated polypeptide chain of 151 amino acids and a molecular mass of 16598 Dalton.
Product Overview
Human TNF expressed in E.coli
Molecular Mass
16.5 kDa
CAT# CSC-CTK0346-50 (50 μg); CAT# CSC-CTK0346-250 (250 μg)
Expression System
Greater than 95% as determined by SDS-PAGE, FPLC and RP-HPLC analysis.
Human TNF-alpha M Variant is fully biologically active when compared to the wild type. The ED50, as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D, is < 0.05ng/ml corresponding to a specific activity of 1 x 10^8 IU/mg.
Endotoxin Level
Less than 1 EU/μg.
Sterile-filtered, white, lyophilized (freeze-dried) powder. The protein was lyophilized after extensive dialysis against 0.5x PBS (pH 7).
Please centrifuge product briefly before opening the vial. The lyophilized rHu TNF- alpha M should be reconstituted in sterile, ultra-pure water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at -20°C for future use.
Storage & Stability
The lyophilized protein, though stable at room temperature for up to 3 weeks, is best stored desiccated at -20°C. Reconstituted rHu TNF-alpha M should be used immediately or stored long- term in undiluted working aliquots at -20°C. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze-thaw cycles.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the Pub Med ID of your paper to get a coupon.

For research use only. Not for any other purpose.

Customer Support & Price Inquiry
Please input "bioarray" as verification code.
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-626-9181
Fax: 1-631-614-7828

Tel: 44-208-144-6005